Pharmacyclics Inc (PCYC) 254.56 $PCYC Takeaways For A

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pharmacyclics Inc (PCYC) 254.56 $PCYC

Takeaways For A Historic Week In The Bond Market: Pharma M&A
Ploutos - at Seeking Alpha - Sun Mar 08, 1:55PM CDT

AGN: 233.51 (-1.90), JNJ: 100.11 (-2.41), ACT: 289.92 (-5.78), VRX: 198.71 (-5.24), PCYC: 254.56 (+0.34), SLXP: 158.01 (+0.57), GM: 36.84 (-0.77), ABBV: 55.64 (-1.22), VZ: 48.29 (-0.63), VOD: 32.97 (-1.40)

Top 5 IBD 50 Drug Stocks Thriving Via Acquisitions
at Investor's Business Daily - Sat Mar 07, 7:02AM CST
The recent flurry of deal-making in the drug sector has put the spotlight on other top-rated drugmakers that have grown with the help of savvy mergers and acquisitions. In just the past week, AbbVie (ABBV) agreed to buy Pharmacyclics (PCYC) for $21...
AGN: 233.51 (-1.90), MNK: 121.33 (-0.37), JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), ACT: 289.92 (-5.78), VRX: 198.71 (-5.24), PCYC: 254.56 (+0.34), OMED: 27.55 (-0.12), AKRX: 49.83 (-1.05), SLXP: 158.01 (+0.57), ABBV: 55.64 (-1.22), CELG: 118.03 (-2.68)

No Sell Signals As Leaders Hold Their Ground
at Investor's Business Daily - Fri Mar 06, 5:57PM CST
A pretty miserable day for the major indexes failed to trigger sell signals among IBD 50 stocks. Only four stocks on the elite list of growth names managed gains, and those gains were small as the Dow Jones industrials, the S&P 500 and the Nasdaq all...
AMBA: 64.22 (-0.17), MNST: 136.62 (-3.41), GPRO: 40.13 (-0.95), PCYC: 254.56 (+0.34), PZZA: 59.86 (-2.07), CRTO: 42.03 (-1.64), ABBV: 55.64 (-1.22), ATHM: 43.84 (-2.99), BITA: 67.00 (-6.46)

Pharmacyclics Set to Be Acquired by AbbVie for $21B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 4:21PM CST
Pharmacyclics Inc.'s shares were up after a definitive agreement was announced under which AbbVie Inc. will acquire Pharmacyclics.
JNJ: 100.11 (-2.41), PCYC: 254.56 (+0.34), ABBV: 55.64 (-1.22), THRX: 19.60 (-0.26), NVS: 97.46 (-1.49)

Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
PCYC: 254.56 (+0.34), MDT: 76.48 (-2.02), ARWR: 7.75 (-0.19), SPHS: 0.70 (-0.03), BSX: 16.56 (-0.41), MDVN: 126.55 (-0.53), JNJ: 100.11 (-2.41), AAC: 29.30 (-2.80), ABBV: 55.64 (-1.22), SNY: 47.42 (-0.94), SMMT: 10.29 (+0.10), ARNA: 4.32 (+0.09), XLRN: 40.55 (-0.79), MNK: 121.33 (-0.37), AQXP: 10.49 (+0.43), PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), GSK: 46.73 (-0.87), BMY: 65.12 (-0.93), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), OREX: 7.10 (-0.91), PODD: 32.24 (+0.26), GERN: 3.50 (-0.28), TEVA: 56.40 (-0.11), TCON: 17.57 (+0.36), NVS: 97.46 (-1.49)

Stock Market News for March 06, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 9:10AM CST
Markets snapped a two-day losing streak on Thursday, somewhat boosted by the ECB announcing a trillion-dollar stimulus plan that will kick off on Monday
BIIB: 417.63 (-7.98), JNJ: 100.11 (-2.41), PCYC: 254.56 (+0.34), ADP: 86.00 (-0.75), MDT: 76.48 (-2.02), GILD: 101.81 (-1.61), ABBV: 55.64 (-1.22), BMY: 65.12 (-0.93)

It's All About Execution - Cramer's Mad Money (3/5/15)
SA Editor Mohit Manghnani - Seeking Alpha - Fri Mar 06, 6:31AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, March 5. Cramer started the show by talking about the lost art of valuing execution. He is of the opinion that stocks run due to good leadership and perfect...
GPRO: 40.13 (-0.95), AMZN: 380.09 (-7.74), TSLA: 193.88 (-6.75), GD: 134.60 (-1.83), KR: 74.35 (+0.04), PCYC: 254.56 (+0.34), FB: 80.00 (-1.21), UTX: 119.43 (-1.36), NOC: 160.41 (-2.87), WMT: 82.59 (-0.98), LVS: 55.09 (-1.27), LPI: 11.63 (-0.04), BA: 153.12 (-1.35), GOOG: 567.68 (-7.65), NFLX: 454.12 (-13.53), ISIS: 70.44 (-1.32), TGT: 77.21 (-0.99), COST: 149.54 (-1.63), RCPT: 140.09 (-1.10), GOOGL: 572.90 (-8.53), ABBV: 55.64 (-1.22), OA: 68.73 (+0.98), CRM: 64.56 (-1.03)

Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect?
at The Street - Thu Mar 05, 7:27PM CST
Cramer says what seems overvalued on paper today might surprise you and be in a whole new category tomorrow.
BID: 41.05 (-0.68), TSLA: 193.88 (-6.75), GWRE: 52.98 (-0.06), ZIOP: 13.38 (-0.43), GE: 25.42 (-0.40), LMT: 197.66 (-1.44), PCYC: 254.56 (+0.34), BX: 38.75 (-0.39), BMRN: 113.77 (+0.27), UTX: 119.43 (-1.36), HZO: 25.64 (+0.21), XOM: 85.63 (-1.11), CZR: 9.63 (-0.53), SBUX: 92.21 (-1.42), ETP: 57.31 (-0.74), SSYS: 62.34 (-1.97), RCPT: 140.09 (-1.10), COST: 149.54 (-1.63), ABBV: 55.64 (-1.22), TRAK: 40.21 (-0.51), ROL: 33.79 (-0.21), OA: 68.73 (+0.98), MOV: 23.86 (-0.59), MBLY: 37.84 (+0.82), CSCO: 28.92 (-0.38), URI: 90.50 (-1.56), CTRL: 12.27 (-0.15), AMZN: 380.09 (-7.74), GPRO: 40.13 (-0.95), KR: 74.35 (+0.04), WFC: 54.59 (-0.25), NXPI: 98.48 (-0.19), BMY: 65.12 (-0.93), BA: 153.12 (-1.35), HPQ: 33.18 (-0.82), DRI: 62.71 (-1.50), ISIS: 70.44 (-1.32), MCD: 97.13 (-1.98), CVX: 103.55 (-1.18), BABA: 84.40 (-1.70)

Irish Highlanders: Drug Stocks Mallinckrodt, Horizon Pharma Rally
at Investor's Business Daily - Thu Mar 05, 5:32PM CST
Drugmakers seized market headlines Thursday when Pharmacyclics (PCYC) spiked 10% on word that it would be acquired by AbbVie (ABBV) in a $21 billion cash and stock deal. The news sent AbbVie down 5% in heavy trade, but also launched a mild rally...
MNK: 121.33 (-0.37), PCYC: 254.56 (+0.34), TARO: 150.82 (-1.25), HZNP: 21.91 (+1.07), ABBV: 55.64 (-1.22), ICLR: 67.15 (-0.69)

Nasdaq stocks posting largest volume increases
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SFST: 16.60 (-0.28), PCYC: 254.56 (+0.34), KYTH: 53.13 (+3.13), HWBK: 13.83 (-0.09), EML: 19.90 (+0.36), CNDO: 3.28 (-0.09), XPLR: 6.05 (-0.03), BOBE: 46.26 (-1.50), NWFL: 28.79 (+0.11), DJCO: 196.34 (-5.36), TSRI: 4.63 (-0.24), HTWO: 9.62 (-0.52)

Most active Nasdaq-traded stocks
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 28.50 (-0.78), PCYC: 254.56 (+0.34), FB: 80.00 (-1.21), INTC: 33.19 (-0.54), OREX: 7.10 (-0.91), FOX: 33.60 (-0.43), GERN: 3.50 (-0.28), FOXA: 34.49 (-0.38), MSFT: 42.36 (-0.75), ZNGA: 2.54 (+0.13), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38)

AbbVie Stock Slides On Pricey Pharmacyclics Deal
at Investor's Business Daily - Thu Mar 05, 3:56PM CST
Big pharma AbbVie's $21 billion deal to acquire hot biotech Pharmacyclics was met with widespread skepticism by AbbVie investors Thursday, sending AbbVie's stock falling 5.7% Thursday. AbbVie (ABBV) announced the cash-and-stock acquisition late...
JNJ: 100.11 (-2.41), PCYC: 254.56 (+0.34), PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), ABBV: 55.64 (-1.22), NVS: 97.46 (-1.49)

Stocks Notch Small Gains Ahead of February Jobs Report
at The Street - Thu Mar 05, 3:43PM CST
Stocks manage to close with gains on Thursday, but just barely ahead of the February jobs report on Friday
PCYC: 254.56 (+0.34), C: 53.06 (-0.50), WYNN: 137.00 (-2.00), BAC: 16.22 (+0.22), LVS: 55.09 (-1.27), JNJ: 100.11 (-2.41), GS: 186.91 (-3.17), JPM: 60.89 (-1.11), MPEL: 23.07 (-1.10), COST: 149.54 (-1.63), ABBV: 55.64 (-1.22), AAPL: 126.60 (+0.19)

AbbVie and Costco are big market movers
AP - Thu Mar 05, 3:35PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
AMBA: 64.22 (-0.17), PCYC: 254.56 (+0.34), COST: 149.54 (-1.63), BOBE: 46.26 (-1.50), PEIX: 11.33 (-0.42), SMTC: 27.06 (+0.76), SWHC: 14.23 (-0.17)

Stocks Rise From Pullback; Pharmacyclics Jumps On Buyout News
at Investor's Business Daily - Thu Mar 05, 3:24PM CST
Stocks rose for the first time in three sessions Thursday, amid mixed economic data and news that the European Central Bank will start its quantitative easing soon. The Nasdaq rose 0.3%, while the Dow Jones industrial average edged up 0.2% and the...
SPLS: 16.05 (-0.45), MNK: 121.33 (-0.37), PCYC: 254.56 (+0.34), MIDD: 105.24 (+0.78), ABBV: 55.64 (-1.22), FL: 59.37 (+2.34), BIG: 48.52 (+0.70)

The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 2:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Puma Biotechnology , a clinical-stage...
PCYC: 254.56 (+0.34), ABBV: 55.64 (-1.22), PBYI: 232.83 (-10.34)

Stocks' Gains Are Limited in Lead-Up to February Jobs Report
at The Street - Thu Mar 05, 2:10PM CST
Stocks regain positive momentum by mid-afternoon. Weaker-than-expected domestic data and the materials sector kept gains limited.
JOY: 39.05 (-0.89), XLB: 50.46 (-0.69), PCYC: 254.56 (+0.34), KR: 74.35 (+0.04), C: 53.06 (-0.50), WYNN: 137.00 (-2.00), BAC: 16.22 (+0.22), LVS: 55.09 (-1.27), TWX: 84.12 (+0.86), GS: 186.91 (-3.17), CPE: 7.30 (+0.14), JPM: 60.89 (-1.11), ANF: 20.17 (-0.04), MPEL: 23.07 (-1.10), COST: 149.54 (-1.63), ABBV: 55.64 (-1.22), AAPL: 126.60 (+0.19)

Stocks Turn Positive; Embraer Falls On Weak Earnings
at Investor's Business Daily - Thu Mar 05, 2:00PM CST
Stocks were modestly higher with an hour to go in Thursday's session as investors weighed mixed U.S. economic data and new European Central Bank stimulus. The Nasdaq was up 0.3%, the Dow Jones industrial average climbed 0.2% and the S&P 500 edged up...
MNK: 121.33 (-0.37), JOY: 39.05 (-0.89), AMBA: 64.22 (-0.17), PCYC: 254.56 (+0.34), ERJ: 33.06 (-0.27), QLYS: 47.45 (-2.29), ABBV: 55.64 (-1.22)

Stocks Nearly Flat In Afternoon; Qualys Climbs To New High
at Investor's Business Daily - Thu Mar 05, 12:30PM CST
Stocks were flat Thursday afternoon as investors weighed mixed U.S. economic data and new stimulus efforts by the European Central Bank. The Nasdaq and the Dow Jones industrial average were both flat, while the S&P 500 slipped 0.1%. All three indexes...
JOY: 39.05 (-0.89), PCYC: 254.56 (+0.34), SFM: 35.49 (+0.30), QLYS: 47.45 (-2.29), ABBV: 55.64 (-1.22)

Nasdaq stocks posting largest percentage increases
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
HYGS: 14.82 (+0.04), DVAX: 21.32 (-0.24), PCYC: 254.56 (+0.34), HYG.TO: 18.75 (+0.25), ATRA: 28.31 (-0.44), CECO: 5.90 (-0.10), OREX: 7.10 (-0.91), EVOK: 6.22 (+0.19), PRQR: 22.86 (+1.49), FCSC: 5.82 (-0.12), KYTH: 53.13 (+3.13), ATTU: 10.02 (-0.41), MRTX: 25.08 (-1.57), PEIX: 11.33 (-0.42)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Applied Digital Corporation Announces Q1 2026 Earnings Call Details

Updated Category News Views 249

Upcoming Conference Call for Fiscal First Quarter 2026 On September 24, 2025, Applied Digital Corporation (Nasdaq: APLD) announced its scheduled conference call for Thursday, October 9, 2025. This call is set for 5:00 p.m. Eastern Time and will encompass key discussions around the company's operations and financial outcomes for the fiscal first quarter that ended on...

Continue Reading
Corero Network Security Expands into Southeast Asia with ONESECURE

Updated Category News Views 147

Corero Network Security Partners with ONESECURE Asia Today, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), a leading authority in DDoS protection, announced its strategic alliance with ONESECURE Asia Pte Ltd. This partnership symbolizes Corero's successful entrance into the Southeast Asian market, emphasizing its commitment to enhancing digital security. Expanding...

Continue Reading
Pinterest Faces Challenges Following Q4 Results and Outlook

Updated Category News Views 231

Pinterest Faces Challenges Following Q4 Results Pinterest recently encountered hurdles as its stock faced significant declines after hours due to disappointing results for the fourth quarter. While the platform showed some growth, it ultimately missed key expectations, causing investors to react cautiously. Quarterly Performance Overview The platform reported...

Continue Reading
Oil Giants Face Difficult Decisions Amidst Price Drops

Updated Category News Views 47

Understanding the Challenges Facing Major Oil Companies As global energy prices decline, major oil companies are grappling with a challenging financial landscape. Analysts predict that these firms will need to borrow substantial amounts or reduce their share repurchase rates in response to falling oil prices. Historical Context of Shareholder Payouts For years, companies...

Continue Reading
Exploring the Rise of Smart Cities in Saudi Arabia

Updated Category News Views 156

Transformation of Urban Living in Saudi Arabia As the world increasingly embraces technological advancements, the Saudi Arabia smart cities market is on a promising trajectory. The valuation of this market is expected to surge from USD 22.2 billion to an impressive USD 112 billion in the coming years, signaling robust growth driven by an impressive compound annual growth...

Continue Reading